References
- Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/https://doi.org/10.1016/j.softx.2015.06.001
- Aguilera, J. J., Zhang, F., Beaudet, J. M., Linhardt, R. J., & Colón, W. (2014). Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A. Biochimie, 104, 70–80. https://doi.org/https://doi.org/10.1016/j.biochi.2014.05.007
- Akçay, S., Akman, B., Ozdemir, H., Eyüboğlu, F. O., Karacan, O., & Ozdemir, N. (2002). Bronchiectasis-related amyloidosis as a cause of chronic renal failure. Renal Failure, 24(6), 815–823. https://doi.org/https://doi.org/10.1081/jdi-120015683
- Andersen, H. C. (1980). Molecular dynamics simulations at constant pressure and/or temperature. The Journal of Chemical Physics, 72(4), 2384–2393. https://doi.org/https://doi.org/10.1063/1.439486
- Barile, L. (1993). Tru-cut needle biopsy of subcutaneous fat in the diagnosis of secondary amyloidosis in rheumatoid arthritis. Archives of Medical Research, 24(2), 189–192.
- Ben-Chetrit, E. (2003). Familial Mediterranean fever (FMF) and renal AA amyloidosis–phenotype-genotype correlation, treatment and prognosis. Journal of Nephrology, 16(3), 431–434.
- Benditt, E. P., & Eriksen, N. (1977). Amyloid protein SAA is associated with high density lipoprotein from human serum. Proceedings of the National Academy of Sciences of the United States of America, 74(9), 4025–4028. https://doi.org/https://doi.org/10.1073/pnas.74.9.4025
- Benditt, E. P., Eriksen, N., & Hanson, R. H. (1979). Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein. Proceedings of the National Academy of Sciences of the United States of America, 76(8), 4092–4096. https://doi.org/https://doi.org/10.1073/pnas.76.8.4092
- Bulum, T., Prkacin, I., Cavrić, G., Sobocan, N., Skurla, B., Duvnjak, L., & Bulimbasić, S. (2011). [Secondary (AA) amyloidosis in Crohn’s disease]. Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti, 65(3), 271–278.
- Childers, M. C., & Daggett, V. (2018). Validating molecular dynamics simulations against experimental observables in light of underlying conformational ensembles. The Journal of Physical Chemistry B, 122(26), 6673–6689. https://doi.org/https://doi.org/10.1021/acs.jpcb.8b02144
- Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log (N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/https://doi.org/10.1063/1.464397
- De Backer, R., & Bourgaux, P. (1967). The nucleic acid of the phi-N bacteriophage. Annales de L'Institut Pasteur, 113(6), 825–832.
- Delano, W. L. (2002). Pymol: An open-source molecular graphics tool. CCP4 Newsletter on Protein Crystallography, 40, 82.
- Dewar, M. J. S., & Thiel, W. (1977). Ground states of molecules. 38. The MNDO method. Approximations and parameters. Journal of the American Chemical Society, 99(15), 4899–4907. Jun. https://doi.org/https://doi.org/10.1021/ja00457a004
- Dewar, M. J. S., Zoebisch, E. G., Healy, E. F., & Stewart, J. J. P. (1985). Development and use of quantum mechanical molecular models. 76. AM1: A new general purpose quantum mechanical molecular model. Journal of the American Chemical Society, 107(13), 3902–3909. https://doi.org/https://doi.org/10.1021/ja00299a024
- Dı́az-Nido, J., Wandosell, F., & Avila, J. (2002). Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases. Peptides, 23(7), 1323–1332. https://doi.org/https://doi.org/10.1016/S0196-9781(02)00068-2
- Ding, F., Tsao, D., Nie, H., & Dokholyan, N. V. (2008). Ab initio folding of proteins with all-atom discrete molecular dynamics. Structure (London, England: 1993), 16(7), 1010–1018. https://doi.org/https://doi.org/10.1016/j.str.2008.03.013
- Elimova, E., Kisilevsky, R., & Ancsin, J. B. (2009). Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: Evidence for a proamyloidogenic histidine molecular switch. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 23(10), 3436–3448. https://doi.org/https://doi.org/10.1096/fj.09-134981
- Esko, J. D. (1991). Genetic analysis of proteoglycan structure, function and metabolism. Current Opinion in Cell Biology, 3(5), 805–816. https://doi.org/https://doi.org/10.1016/0955-0674(91)90054-3
- Fraser, P. E., Nguyen, J. T., Surewicz, W. K., & Kirschner, D. A. (1991). pH-dependent structural transitions of Alzheimer amyloid peptides. Biophysical Journal, 60(5), 1190–1201. https://doi.org/https://doi.org/10.1016/S0006-3495(91)82154-3
- Gabay, C., & Kushner, I. (1999). Acute-phase proteins and other systemic responses to inflammation. The New England Journal of Medicine, 340(6), 448–454. https://doi.org/https://doi.org/10.1056/NEJM199902113400607
- Gallagher, J. T. (1989). The extended family of proteoglycans: Social residents of the pericellular zone. Current Opinion in Cell Biology, 1(6), 1201–1218. https://doi.org/https://doi.org/10.1016/S0955-0674(89)80072-9
- Gao, W., Kim, H., Feng, M., Phung, Y., Xavier, C. P., Rubin, J. S., & Ho, M. (2014). Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy. Hepatology (Baltimore, MD), 60(2), 576–587. https://doi.org/https://doi.org/10.1002/hep.26996
- Goor, W., Krech, U., & Maier, C. (1969). Cytomegalic inclusion disease in adults. Praxis, 58(16), 493–496.
- Gopalakrishnan, C., Al-Subaie, A. M., N, N., Yeh, H.-Y., Tayubi, I. A., & Kamaraj, B. (2019). Prioritization of SNPs in y + LAT-1 culpable of Lysinuric protein intolerance and their mutational impacts using protein-protein docking and molecular dynamics simulation studies. Journal of Cellular Biochemistry, 120(10), 18496–18508. https://doi.org/https://doi.org/10.1002/jcb.29172
- Häcker, U., Nybakken, K., & Perrimon, N. (2005). Heparan sulphate proteoglycans: The sweet side of development. Nature Reviews. Molecular Cell Biology, 6(7), 530–541. https://doi.org/https://doi.org/10.1038/nrm1681
- Hernández, F., Pérez, M., Lucas, J. J., & Avila, J. (2002). Sulfo-glycosaminoglycan content affects PHF-tau solubility and allows the identification of different types of PHFs. Brain Research, 935(1–2), 65–72. https://doi.org/https://doi.org/10.1016/S0006-8993(02)02455-1
- Hunter, J. D. (2007). Matplotlib: A 2D graphics environment. Computing in Science & Engineering, 9(3), 90–95. https://doi.org/https://doi.org/10.1109/MCSE.2007.55
- Jahn, T. R., & Radford, S. E. (2008). Folding versus aggregation: Polypeptide conformations on competing pathways. Archives of Biochemistry and Biophysics, 469(1), 100–117. https://doi.org/https://doi.org/10.1016/j.abb.2007.05.015
- Jensen, F. (2007). Introduction to computational chemistry (2nd ed.). John Wiley & Sons.
- Jin, L., Syrovets, T., Scheller, J. S., Zhang, X., & Simmet, T. (2019). Comparative study on hyaluronic acid binding to murine SAA1.1 and SAA2.2. ACS Omega, 4(8), 13388–13399. https://doi.org/https://doi.org/10.1021/acsomega.9b01590
- Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., Wang, J., Yu, B., Zhang, J., & Bryant, S. H. (2016). PubChem substance and compound databases. Nucleic Acids Research, 44(D1), D1202–1213. https://doi.org/https://doi.org/10.1093/nar/gkv951
- King, V. L., Thompson, J., & Tannock, L. R. (2011). Serum amyloid A in atherosclerosis. Current Opinion in Lipidology, 22(4), 302–307. https://doi.org/https://doi.org/10.1097/MOL.0b013e3283488c39
- Kirkitadze, M. D., Condron, M. M., & Teplow, D. B. (2001). Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. Journal of Molecular Biology, 312(5), 1103–1119. https://doi.org/https://doi.org/10.1006/jmbi.2001.4970
- Kobayashi, H., Tada, S., Fuchigami, T., Okuda, Y., Takasugi, K., Matsumoto, T., Iida, M., Aoyagi, K., Iwashtta, A., Daimaru, Y., & Fujishima, M. (1996). Secondary amyloidosis in patients with rheumatoid arthritis: Diagnostic and prognostic value of gastroduodenal biopsy. Rheumatology, 35(1), 44–49. https://doi.org/https://doi.org/10.1093/rheumatology/35.1.44
- Lachmann, H. J., Goodman, H. J. B., Gilbertson, J. A., Gallimore, J. R., Sabin, C. A., Gillmore, J. D., & Hawkins, P. N. (2007). Natural history and outcome in systemic AA amyloidosis. New England Journal of Medicine, 356(23), 2361–2371. https://doi.org/https://doi.org/10.1056/NEJMoa070265
- Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778–2786. https://doi.org/https://doi.org/10.1021/ci200227u
- Lazaridis, T., & Karplus, M. (1999). Effective energy function for proteins in solution. Proteins: Structure, Function, and Genetics, 35(2), 133–152. https://doi.org/https://doi.org/10.1002/(sici)1097-0134(19990501)35:2 < 133::aid-prot1 > 3.0.co;2-n
- Lee, A., & Streinu, I. (2008). Pebble game algorithms and sparse graphs. Discrete Mathematics, 308(8), 1425–1437. https://doi.org/https://doi.org/10.1016/j.disc.2007.07.104
- Leow, K.-Y., Goh, W. W. B., Tan, S.-Z., Lim, J., Ng, K., Oh, V. M.-S., Low, A. F.-H., & Heng, C.-K. (2013). Variant screening of the serum amyloid A1 gene and functional study of the p.Gly90Asp variant for its role in atherosclerosis. Atherosclerosis, 227(1), 112–117. https://doi.org/https://doi.org/10.1016/j.atherosclerosis.2013.01.003
- Li, Y., Lai-Han Leung, E., Pan, H., Yao, X., Huang, Q., Wu, M., Xu, T., Wang, Y., Cai, J., Li, R., Liu, W., & Liu, L. (2017). Identification of potential genetic causal variants for rheumatoid arthritis by whole-exome sequencing. Oncotarget, 8(67), 111119–111129. https://doi.org/https://doi.org/10.18632/oncotarget.22630
- Lu, J., Yu, Y., Zhu, I., Cheng, Y., & Sun, P. D. (2014). Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis. Proceedings of the National Academy of Sciences of the United States of America, 111(14), 5189–5194. https://doi.org/https://doi.org/10.1073/pnas.1322357111
- Malle, E., Sodin-Semrl, S., & Kovacevic, A. (2009). Serum amyloid A: An acute-phase protein involved in tumour pathogenesis. Cellular and Molecular Life Sciences: CMLS, 66(1), 9–26. https://doi.org/https://doi.org/10.1007/s00018-008-8321-x
- Marhaug, G., & Dowton, S. B. (1994). Serum amyloid A: An acute phase apolipoprotein and precursor of AA amyloid. Bailliere’s Clinical Rheumatology, 8(3), 553–573. https://doi.org/https://doi.org/10.1016/S0950-3579(05)80115-3
- McLaurin, J., Franklin, T., Zhang, X., Deng, J., & Fraser, P. E. (1999). Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. European Journal of Biochemistry, 266(3), 1101–1110. https://doi.org/https://doi.org/10.1046/j.1432-1327.1999.00957.x
- Meshach Paul, D., & Rajasekaran, R. (2017). In silico approach to explore the disruption in the molecular mechanism of human hyaluronidase 1 by mutant E268K that directs Natowicz syndrome. European Biophysics Journal, 46(2), 157–169. https://doi.org/https://doi.org/10.1007/s00249-016-1151-0
- Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/https://doi.org/10.1002/jcc.21256
- Motamedi-Shad, N., Monsellier, E., Torrassa, S., Relini, A., & Chiti, F. (2009). Kinetic analysis of amyloid formation in the presence of heparan sulfate: Faster unfolding and change of pathway. The Journal of Biological Chemistry, 284(43), 29921–29934. https://doi.org/https://doi.org/10.1074/jbc.M109.018747
- Nagarajan, A., Malvi, P., & Wajapeyee, N. (2018). Heparan sulfate and heparan sulfate proteoglycans in cancer initiation and progression. Frontiers in Endocrinology, 9, 483. https://doi.org/https://doi.org/10.3389/fendo.2018.00483
- Naiki, H., & Nagai, Y. (2009). Molecular pathogenesis of protein misfolding diseases: Pathological molecular environments versus quality control systems against misfolded proteins. Journal of Biochemistry, 146(6), 751–756. https://doi.org/https://doi.org/10.1093/jb/mvp119
- Noborn, F., Ancsin, J. B., Ubhayasekera, W., Kisilevsky, R., & Li, J.-P. (2012). Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation. The Journal of Biological Chemistry, 287(30), 25669–25677. https://doi.org/https://doi.org/10.1074/jbc.M112.363895
- Ogita, M., Hoshino, J., Sogawa, Y., Sawa, N., Katori, H., Takemoto, F., Ubara, Y., Hara, S., Miyakoshi, S., & Takaichi, K. (2007). Multicentric Castleman disease with secondary AA renal amyloidosis, nephrotic syndrome and chronic renal failure, remission after high-dose melphalan and autologous stem cell transplantation. Clinical Nephrology, 68(3), 171–176. https://doi.org/https://doi.org/10.5414/cnp68171
- Papy-Garcia, D., Christophe, M., Huynh, M. B., Fernando, S., Ludmilla, S., Sepulveda-Diaz, J. E., & Raisman-Vozari, R. (2011). Glycosaminoglycans, protein aggregation and neurodegeneration. Current Protein & Peptide Science, 12(3), 258–268. https://doi.org/https://doi.org/10.2174/138920311795860188
- Paret, C., Schön, Z., Szponar, A., & Kovacs, G. (2010). Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome. European Urology, 57(5), 859–866. https://doi.org/https://doi.org/10.1016/j.eururo.2009.08.014
- Parmelee, D. C., Titani, K., Ericsson, L. H., Eriksen, N., Benditt, E. P., & Walsh, K. A. (1982). Amino acid sequence of amyloid-related apoprotein (apoSAA1) from human high-density lipoprotein. Biochemistry, 21(14), 3298–3303. https://doi.org/https://doi.org/10.1021/bi00257a008
- Patel, J. S., Berteotti, A., Ronsisvalle, S., Rocchia, W., & Cavalli, A. (2014). Steered molecular dynamics simulations for studying protein-ligand interaction in cyclin-dependent kinase 5. Journal of Chemical Information and Modeling, 54(2), 470–480. https://doi.org/https://doi.org/10.1021/ci4003574
- Pierce, B. L., Ballard-Barbash, R., Bernstein, L., Baumgartner, R. N., Neuhouser, M. L., Wener, M. H., Baumgartner, K. B., Gilliland, F. D., Sorensen, B. E., McTiernan, A., & Ulrich, C. M. (2009). Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. Journal of Clinical Oncology, 27(21), 3437–3444. https://doi.org/https://doi.org/10.1200/JCO.2008.18.9068
- Pinney, J. H., & Lachmann, H. J. (2012). Systemic AA amyloidosis. In J. R. Harris (Ed.), Protein aggregation and fibrillogenesis in cerebral and systemic amyloid disease (Vol. 65, pp. 541–564). Springer.
- Rader, A. J., Hespenheide, B. M., Kuhn, L. A., & Thorpe, M. F. (2002). Protein unfolding: Rigidity lost. Proceedings of the National Academy of Sciences, 99(6), 3540–3545. https://doi.org/https://doi.org/10.1073/pnas.062492699
- Sakuraba, S., & Kono, H. (2016). Spotting the difference in molecular dynamics simulations of biomolecules. The Journal of Chemical Physics, 145(7), 074116. https://doi.org/https://doi.org/10.1063/1.4961227
- Sano, T., Huang, W., Hall, J. A., Yang, Y., Chen, A., Gavzy, S. J., Lee, J.-Y., Ziel, J. W., Miraldi, E. R., Domingos, A. I., Bonneau, R., & Littman, D. R. (2015). An IL-23R/IL-22 circuit regulates epithelial serum amyloid A to promote local effector Th17 responses. Cell, 163(2), 381–393. https://doi.org/https://doi.org/10.1016/j.cell.2015.08.061
- Sarrazin, S., Lamanna, W. C., & Esko, J. D. (2011). Heparan sulfate proteoglycans. Cold Spring Harbor Perspectives in Biology, 3(7), a004952. https://doi.org/https://doi.org/10.1101/cshperspect.a004952
- Schultz, V., Suflita, M., Liu, X., Zhang, X., Yu, Y., Li, L., Green, D. E., Xu, Y., Zhang, F., DeAngelis, P. L., Liu, J., & Linhardt, R. J. (2017). Heparan sulfate domains required for fibroblast growth factor 1 and 2 signaling through fibroblast growth factor receptor 1c. The Journal of Biological Chemistry, 292(6), 2495–2509. https://doi.org/https://doi.org/10.1074/jbc.M116.761585
- Sethi, S., Vrana, J. A., Theis, J. D., Leung, N., Sethi, A., Nasr, S. H., Fervenza, F. C., Cornell, L. D., Fidler, M. E., & Dogan, A. (2012). Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney International, 82(2), 226–234. https://doi.org/https://doi.org/10.1038/ki.2012.108
- Shimojima, Y., Takei, Y.-I., Tazawa, K.-I., Gono, T., Fushimi, T., Matsuda, M., Hoshii, Y., & Ikeda, S.-I. (2006). Histopathological regression of systemic AA amyloidosis after surgical treatment of a localized Castleman’s disease. Amyloid: The International Journal of Experimental and Clinical Investigation: The Official Journal of the International Society of Amyloidosis, 13(3), 184–186. https://doi.org/https://doi.org/10.1080/13506120600876930
- Snow, A. D., Wight, T. N., Nochlin, D., Koike, Y., Kimata, K., DeArmond, S. J., Prusiner, S. B. (1990). Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. Laboratory Investigation, 63(5), 601–611.
- Srinivasan, E., & Rajasekaran, R. (2017). Computational investigation of the human SOD1 mutant, Cys146Arg, that directs familial amyotrophic lateral sclerosis. Molecular Biosystems, 13(8), 1495–1503. https://doi.org/https://doi.org/10.1039/c7mb00106a
- Srinivasan, E., & Rajasekaran, R. (2018). Quantum chemical and molecular mechanics studies on the assessment of interactions between resveratrol and mutant SOD1 (G93A) protein. Journal of Computer-Aided Molecular Design, 32(12), 1347–1361. https://doi.org/https://doi.org/10.1007/s10822-018-0175-1
- Stewart, J. J. P. (1989a). Optimization of parameters for semiempirical methods II. Applications. Journal of Computational Chemistry, 10(2), 221–264. https://doi.org/https://doi.org/10.1002/jcc.540100209
- Stewart, J. J. P. (1989b). Optimization of parameters for semiempirical methods I. Method. Journal of Computational Chemistry, 10(2), 209–220. https://doi.org/https://doi.org/10.1002/jcc.540100208
- Stewart, J. J. P. (2004). Optimization of parameters for semiempirical methods IV: Extension of MNDO, AM1, and PM3 to more main group elements. Journal of Molecular Modeling, 10(2), 155–164. https://doi.org/https://doi.org/10.1007/s00894-004-0183-z
- Stringer, S. E. (2006). The role of heparan sulphate proteoglycans in angiogenesis. Biochemical Society Transactions, 34(Pt 3), 451–453. https://doi.org/https://doi.org/10.1042/BST0340451
- Thirumal Kumar, D., Jerushah Emerald, L., George Priya Doss, C., Sneha, P., Siva, R., Charles Emmanuel Jebaraj, W., & Zayed, H. (2018). Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2. Metabolic Brain Disease, 33(5), 1699–1710. https://doi.org/https://doi.org/10.1007/s11011-018-0278-3
- Vriend, G. (1990). WHAT IF: A molecular modeling and drug design program. Journal of Molecular Graphics, 8(1), 52–56. https://doi.org/https://doi.org/10.1016/0263-7855(90)80070-V
- Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174. https://doi.org/https://doi.org/10.1002/jcc.20035
- Xu, D., & Esko, J. D. (2014). Demystifying heparan sulfate-protein interactions. Annual Review of Biochemistry, 83, 129–157. https://doi.org/https://doi.org/10.1146/annurev-biochem-060713-035314
- Young, I. D., Ailles, L., Narindrasorasak, S., Tan, R., & Kisilevsky, R. (1992). Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type II diabetes mellitus. Archives of Pathology & Laboratory Medicine, 116(9), 951–954.
- Zewinger, S., Drechsler, C., Kleber, M. E., Dressel, A., Riffel, J., Triem, S., Lehmann, M., Kopecky, C., Säemann, M. D., Lepper, P. M., Silbernagel, G., Scharnagl, H., Ritsch, A., Thorand, B., de las Heras Gala, T., Wagenpfeil, S., Koenig, W., Peters, A., Laufs, U., … März, W. (2015). Serum amyloid A: High-density lipoproteins interaction and cardiovascular risk. European Heart Journal, 36(43), 3007–3016. https://doi.org/https://doi.org/10.1093/eurheartj/ehv352